𝔖 Bobbio Scriptorium
✦   LIBER   ✦

γ-secretase inhibitors for the treatment of Alzheimer's disease

✍ Scribed by Wen-Lian Wu; Lili Zhang

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
105 KB
Volume
70
Category
Article
ISSN
0272-4391

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alternative processing of γ-secretase su
Alternative processing of γ-secretase substrates in common forms of mild cognitive impairment and alzheimer's disease: Evidence for γ-secretase dysfunction
✍ Saori Hata; Sayaka Fujishige; Yoichi Araki; Miyako Taniguchi; Katsuya Urakami; E 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 331 KB 👁 1 views

Objective: The most common pathogenesis for familial Alzheimer's disease (FAD) involves misprocessing (or alternative processing) of the amyloid precursor protein (APP) by c-secretase due to mutations of the presenilin 1 (PS1) gene. This misprocessing/alternative processing leads to an increase in t

Initiating and monitoring cholinesterase
Initiating and monitoring cholinesterase inhibitor treatment for Alzheimer's disease
✍ Gregory R. J. Swanwick; Brian A. Lawlor 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 1 views

The availability of acetylcholinesterase inhibitors for the treatment of Alzheimer's disease raises a number of clinical and ethical questions. Many of the guidelines published in an attempt to tackle these questions lack either clinical or scienti®c validity. Against this background a model is prop